NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
-31.07%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$364M
AUM Growth
+$364M
Cap. Flow
-$1.66M
Cap. Flow %
-0.46%
Top 10 Hldgs %
90.27%
Holding
20
New
Increased
4
Reduced
1
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DCPH
1
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$86.1M 23.65% 4,104,140
PRNB
2
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$71.9M 19.74% 2,625,713
APTX
3
DELISTED
Aptinyx Inc. Common Stock
APTX
$54.4M 14.94% 3,290,079
STIM icon
4
Neuronetics
STIM
$220M
$29.9M 8.2% 1,543,115
ARVN icon
5
Arvinas
ARVN
$568M
$29.3M 8.05% 2,283,048
WVE icon
6
Wave Life Sciences
WVE
$1.53B
$17.9M 4.91% 425,429
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.71B
$12.7M 3.49% 444,708
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$11.4M 3.13% 900,501
COGT icon
9
Cogent Biosciences
COGT
$1.69B
$7.9M 2.17% 1,795,545
ITRM icon
10
Iterum Therapeutics
ITRM
$30.2M
$7.3M 2% 1,456,303
SRRA
11
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$6.63M 1.82% 5,020,446
AFMD
12
DELISTED
Affimed
AFMD
$5.6M 1.54% 1,800,000
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$2.92B
$5.03M 1.38% 167,700
TECX
14
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$3.59M 0.99% 215,550 +43,200 +25% +$719K
CMRX
15
DELISTED
Chimerix, Inc.
CMRX
$3.47M 0.95% 1,350,000 +350,000 +35% +$900K
TARA icon
16
Protara Therapeutics
TARA
$120M
$3.46M 0.95% 1,523,200 +23,200 +2% +$52.7K
ARAV
17
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.42M 0.94% 970,659 -1,507,741 -61% -$5.31M
NERV icon
18
Minerva Neurosciences
NERV
$16.5M
$2.85M 0.78% 423,300 +293,300 +226% +$1.98M
PDSB icon
19
PDS Biotechnology
PDSB
$57.8M
$753K 0.21% 2,344,868
AVEO
20
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$643K 0.18% 402,118